GlassScriptPhysician profile
Joanna E Gernsback
NPI 1215252440
$20,070.89
in general payments reported to CMS, 2019-2025
14 companies · $181 in 2025
The $181 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,651 · 2020: $365 · 2021: $3,370 · 2022: $2,653 · 2023: $3,247 · 2024: $1,605 · 2025: $181.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,585 · Food and Beverage: $1,447.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,585.30 |
| Food and Beverage | $1,446.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $8,821.19 | 2019-2022 | |
| Aesculap, INC. | $2,953.22 | 2023-2024 | Progav 2.0, No Applicable Marketed Product Name |
| Zimvie INC. | $2,496.89 | 2022-2023 | |
| Medtronic, INC. | $2,106.08 | 2021 | |
| Zimmer Biomet Holdings, INC. | $1,499.15 | 2020-2021 | |
| Medtronic USA, INC. | $1,357.41 | 2019 | |
| Kuros Biosciences USA, INC | $243.37 | 2024-2025 | Magnetos |
| Alafair Biosciences, INC. | $193.25 | 2024-2025 | Versawrap |
| Monteris Medical Corporation | $138.69 | 2021-2024 | Neuroblate |
| Livanova USA, INC. | $76.15 | 2019 | |
| Stryker Corporation | $73.41 | 2024 | Mesa Small Stature Spinal System |
| Orthofix Medical, INC. | $59.48 | 2023 | 7d Surgical System |
| Depuy Synthes Sales INC. | $35.80 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $16.80 | 2023 | Andexxa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joanna Gernsback listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.